• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过基于磁共振成像的血流动力学组织特征改善胶质母细胞瘤患者预后的评估

Improving the estimation of prognosis for glioblastoma patients by MR based hemodynamic tissue signatures.

作者信息

Fuster-Garcia Elies, Juan-Albarracín Javier, García-Ferrando Germán A, Martí-Bonmatí Luis, Aparici-Robles Fernando, García-Gómez Juan M

机构信息

Instituto Universitario de Tecnologías de la Información y Comunicaciones, Universitat Politècnica de València, València, Spain.

Medical Imaging Department, La Fe Polytechnics and University Hospital, València, Spain.

出版信息

NMR Biomed. 2018 Dec;31(12):e4006. doi: 10.1002/nbm.4006. Epub 2018 Sep 21.

DOI:10.1002/nbm.4006
PMID:30239058
Abstract

Advanced MRI and molecular markers have been raised as crucial to improve prognostic models for patients having glioblastoma (GBM) lesions. In particular, different MR perfusion based markers describing vascular intrapatient heterogeneity have been correlated with tumor aggressiveness, and represent key information to understand tumor resistance against effective therapies of these neoplasms. Recently, hemodynamic tissue signature (HTS) markers based on MR perfusion images have been demonstrated to be useful for describing the heterogeneity of GBM at the voxel level, as well as demonstrating significant correlations with the patient's overall survival. In this work, we analyze the abilities of these markers to improve the conventional prognostic models based on clinical, morphological, and demographic features. Our results, in both the regression and classification tests, show that inclusion of the HTS markers improves the reliability of prognostic models. The HTS method is fully automatic and it is available for research use at http://www.oncohabitats.upv.es.

摘要

先进的磁共振成像(MRI)和分子标志物对于改善胶质母细胞瘤(GBM)患者的预后模型至关重要。特别是,描述患者体内血管异质性的不同基于磁共振灌注的标志物已与肿瘤侵袭性相关联,并且是理解这些肿瘤对有效治疗的耐药性的关键信息。最近,基于磁共振灌注图像的血流动力学组织特征(HTS)标志物已被证明可用于在体素水平描述GBM的异质性,并与患者的总生存期显示出显著相关性。在这项工作中,我们分析了这些标志物基于临床、形态学和人口统计学特征改善传统预后模型的能力。我们在回归和分类测试中的结果表明,纳入HTS标志物可提高预后模型的可靠性。HTS方法是完全自动化的,可在http://www.oncohabitats.upv.es上用于研究。

相似文献

1
Improving the estimation of prognosis for glioblastoma patients by MR based hemodynamic tissue signatures.通过基于磁共振成像的血流动力学组织特征改善胶质母细胞瘤患者预后的评估
NMR Biomed. 2018 Dec;31(12):e4006. doi: 10.1002/nbm.4006. Epub 2018 Sep 21.
2
ONCOhabitats: A system for glioblastoma heterogeneity assessment through MRI.ONCOhabitats:一种通过 MRI 评估胶质母细胞瘤异质性的系统。
Int J Med Inform. 2019 Aug;128:53-61. doi: 10.1016/j.ijmedinf.2019.05.002. Epub 2019 May 16.
3
Algorithmic three-dimensional analysis of tumor shape in MRI improves prognosis of survival in glioblastoma: a multi-institutional study.MRI中肿瘤形状的算法三维分析改善胶质母细胞瘤的生存预后:一项多机构研究
J Neurooncol. 2017 Mar;132(1):55-62. doi: 10.1007/s11060-016-2359-7. Epub 2017 Jan 10.
4
Glioblastoma: Vascular Habitats Detected at Preoperative Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging Predict Survival.胶质母细胞瘤:术前动态磁敏感对比增强灌注磁共振成像检测到的血管生境可预测生存。
Radiology. 2018 Jun;287(3):944-954. doi: 10.1148/radiol.2017170845. Epub 2018 Jan 19.
5
A Fully-Automatic Multiparametric Radiomics Model: Towards Reproducible and Prognostic Imaging Signature for Prediction of Overall Survival in Glioblastoma Multiforme.全自动多参数放射组学模型:预测多形性胶质母细胞瘤总生存期的可重复且预后的成像特征。
Sci Rep. 2017 Oct 30;7(1):14331. doi: 10.1038/s41598-017-14753-7.
6
Robust association between vascular habitats and patient prognosis in glioblastoma: An international multicenter study.胶质母细胞瘤中血管生境与患者预后之间的强关联:一项国际多中心研究。
J Magn Reson Imaging. 2020 May;51(5):1478-1486. doi: 10.1002/jmri.26958. Epub 2019 Oct 26.
7
Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival.癌症基因组图谱胶质母细胞瘤患者队列的多中心影像结果研究:总生存期和无进展生存期的影像预测因素
Neuro Oncol. 2015 Nov;17(11):1525-37. doi: 10.1093/neuonc/nov117. Epub 2015 Jul 22.
8
Radiomic Analysis Reveals Prognostic Information in T1-Weighted Baseline Magnetic Resonance Imaging in Patients With Glioblastoma.放射组学分析揭示胶质母细胞瘤患者T1加权基线磁共振成像中的预后信息。
Invest Radiol. 2017 Jun;52(6):360-366. doi: 10.1097/RLI.0000000000000349.
9
Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme.胶质母细胞瘤 516 例连续系列的总生存率、预后因素和重复手术。
Acta Neurol Scand. 2010 Sep;122(3):159-67. doi: 10.1111/j.1600-0404.2010.01350.x. Epub 2010 Mar 18.
10
Texture Feature Ratios from Relative CBV Maps of Perfusion MRI Are Associated with Patient Survival in Glioblastoma.灌注MRI相对脑血容量图的纹理特征比率与胶质母细胞瘤患者的生存率相关。
AJNR Am J Neuroradiol. 2016 Jan;37(1):37-43. doi: 10.3174/ajnr.A4534. Epub 2015 Oct 15.

引用本文的文献

1
The prognostic relevance of a gene expression signature in MRI-defined highly vascularized glioblastoma.MRI定义的高血管化胶质母细胞瘤中基因表达特征的预后相关性
Heliyon. 2024 May 17;10(11):e31175. doi: 10.1016/j.heliyon.2024.e31175. eCollection 2024 Jun 15.
2
Tumour Size and Overall Survival in a Cohort of Patients with Unifocal Glioblastoma: A Uni- and Multivariable Prognostic Modelling and Resampling Study.单灶性胶质母细胞瘤患者队列中的肿瘤大小与总生存期:单变量和多变量预后建模及重采样研究
Cancers (Basel). 2024 Mar 27;16(7):1301. doi: 10.3390/cancers16071301.
3
Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary Study.
通过PET和MRI解码恶性胶质瘤的异质性以进行缺氧、灌注和扩散成像的空间栖息地分析:一项初步研究
Front Neurosci. 2022 Jul 13;16:885291. doi: 10.3389/fnins.2022.885291. eCollection 2022.
4
Hemodynamic Imaging in Cerebral Diffuse Glioma-Part A: Concept, Differential Diagnosis and Tumor Grading.脑弥漫性胶质瘤的血流动力学成像——A部分:概念、鉴别诊断及肿瘤分级
Cancers (Basel). 2022 Mar 10;14(6):1432. doi: 10.3390/cancers14061432.
5
Hemodynamic Imaging in Cerebral Diffuse Glioma-Part B: Molecular Correlates, Treatment Effect Monitoring, Prognosis, and Future Directions.脑弥漫性胶质瘤的血流动力学成像 - 第二部分:分子关联、治疗效果监测、预后及未来方向
Cancers (Basel). 2022 Mar 5;14(5):1342. doi: 10.3390/cancers14051342.
6
Lack of Benefit of Extending Temozolomide Treatment in Patients with High Vascular Glioblastoma with Methylated .延长替莫唑胺治疗对甲基化高血管性胶质母细胞瘤患者无益处
Cancers (Basel). 2021 Oct 29;13(21):5420. doi: 10.3390/cancers13215420.
7
Survival prediction of glioblastoma patients-are we there yet? A systematic review of prognostic modeling for glioblastoma and its clinical potential.胶质母细胞瘤患者的生存预测-我们做到了吗?胶质母细胞瘤预后模型的系统评价及其临床潜力。
Neurosurg Rev. 2021 Aug;44(4):2047-2057. doi: 10.1007/s10143-020-01430-z. Epub 2020 Nov 6.
8
Higher vascularity at infiltrated peripheral edema differentiates proneural glioblastoma subtype.浸润性周边水肿的高血管性可区分神经前体细胞型胶质母细胞瘤。
PLoS One. 2020 Oct 14;15(10):e0232500. doi: 10.1371/journal.pone.0232500. eCollection 2020.
9
MGMT methylation may benefit overall survival in patients with moderately vascularized glioblastomas.MGMT 甲基化可能有益于血管中度丰富的胶质母细胞瘤患者的总生存期。
Eur Radiol. 2021 Mar;31(3):1738-1747. doi: 10.1007/s00330-020-07297-4. Epub 2020 Oct 1.